4len: Difference between revisions

Revision as of 08:51, 16 April 2014

Unreleased structure

The entry 4len is ON HOLD until Paper Publication

Authors: Tondi, D.

Description: CTM-M-9 in complex with the broad spectrum inhibitor (2E)-3-[2-(dihydroxyboranyl)-1-benzothiophen-3-yl]prop-2-enoic acid

Revision as of 07:00, 19 March 2014 view source OCA (talk \| contribs) Bots, Bureaucrats, journal, Administrators 3,328,572 edits No edit summary ← Older edit		Revision as of 08:51, 16 April 2014 view source OCA (talk \| contribs) Bots, Bureaucrats, journal, Administrators 3,328,572 edits No edit summary Newer edit →
Line 5:		Line 5:
	Authors: Tondi, D.		Authors: Tondi, D.

	Description: ~~CTX~~-M9 in complex with 3-[2-(~~4,4,5,5-Tetramethyl~~-[1~~,3,2]dioxaborolan~~-~~2-yl)-benzo[b]thiophen~~-3-yl]-~~acrylic~~ acid		Description: CTM-M-9 in complex with the broad spectrum inhibitor (2E)-3-[2-(dihydroxyboranyl)-1-benzothiophen-3-yl]prop-2-enoic acid